TAK-218 is a promising candidate as an agent tor central nervous system trauma and ischemia. TAK-218 exhibits potent scavenging activity and antioxidative activity. TAK-218 also inhibits dopamine release[1].
References
[1] Morio MURAKAMI, et al. ESR Study on the Antioxidant Activity of TAK-218 in Biological Model Membranes. Chem. Pharm. Bull. 48(6)784-792 (2000).
